Effects of Sleep Quality, Anxiety, and Digital Behavior on Labor Progression in Term Primiparous Women: A Prospective Observational Study
SAD-LABOR
2 other identifiers
observational
127
1 country
1
Brief Summary
This prospective observational study evaluates whether maternal sleep quality, anxiety levels, and nighttime digital behavior are associated with labor progression among term primiparous women. Sleep quality and anxiety are assessed before the onset of labor during routine antenatal visits using validated instruments, including the Pittsburgh Sleep Quality Index (PSQI) and the Beck Anxiety Inventory (BAI). Nighttime digital behavior characteristics, such as screen exposure and smartphone use prior to sleep, are recorded through standardized antenatal interviews. Labor outcomes, including the duration of the latent, active, and second stages of labor, requirement for oxytocin augmentation, use of analgesia, and mode of delivery, are prospectively documented from hospital admission until birth. By examining behavioral and psychological factors prior to labor onset, the study aims to determine whether poor sleep quality, increased anxiety, or irregular nighttime digital activity are associated with prolonged labor phases or greater need for obstetric interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2025
CompletedFirst Submitted
Initial submission to the registry
November 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedFirst Posted
Study publicly available on registry
December 23, 2025
CompletedDecember 23, 2025
December 1, 2025
4 months
November 23, 2025
December 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of Active Labor
Time in minutes from the onset of active labor (defined as cervical dilatation of ≥4 cm with regular contractions) to full cervical dilatation (10 cm). Data will be obtained prospectively from electronic delivery records.
From onset of active labor (≥4 cm) until full cervical dilatation (10 cm), typically within 2 to 12 hours.
Secondary Outcomes (8)
Duration of Latent Phase of Labor
From onset of regular contractions until onset of active labor (≥4 cm), typically lasting up to 20 hours.
Duration of Second Stage of Labor
From full dilatation (10 cm) until birth, typically lasting up to 3 hours.
Oxytocin Augmentation Requirement
From admission in active labor (≥4 cm) until delivery, typically within 2 to 12 hours.
Mode of Delivery
Assessed at delivery.
Use of Epidural Analgesia
From onset of active labor (≥4 cm) until delivery, typically within 2 to 12 hours.
- +3 more secondary outcomes
Study Arms (1)
Primiparous Cohort
Term primiparous women assessed for sleep quality, anxiety, digital behavior, and followed through spontaneous labor.
Interventions
Observational study with no assigned treatment or intervention.
Eligibility Criteria
This study population consists of term primiparous pregnant women who attended routine antenatal follow-up at Izmir Tepecik Training and Research Hospital and subsequently experienced spontaneous onset of labor. All participants were healthy, low-risk obstetric patients with singleton, cephalic presentations and no medical or obstetric complications.
You may qualify if:
- Pregnant women at ≥ 37 weeks of gestation
- Completion of PSQI (sleep quality) and BAI (anxiety) assessments during antenatal clinic visit
- Singleton pregnancy
- Cephalic presentation
- Age 18 to 50 years
- Planning to deliver at the study hospital
- Able to provide informed consent
You may not qualify if:
- Multiple pregnancy
- Non-cephalic presentation
- Delivery occurring at another hospital or birth center
- Elective planned cesarean delivery
- Major fetal anomaly
- Placenta previa or placenta accreta spectrum
- Preeclampsia, eclampsia, HELLP syndrome
- Gestational diabetes requiring insulin
- Chronic medical disorders affecting labor physiology
- Use of sedative, hypnotic, or psychotropic medications
- Inability to complete questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tepecik Training and Research Hospital
Izmir, 35020, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Obstetrics and Gynecology Specialist, Principal Investigator
Study Record Dates
First Submitted
November 23, 2025
First Posted
December 23, 2025
Study Start
August 10, 2025
Primary Completion
November 25, 2025
Study Completion
November 30, 2025
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. The dataset contains sensitive clinical information from pregnant women and cannot be made publicly available due to institutional and national data protection regulations. Summary results will be published in peer-reviewed journals, but no individual-level data will be released.